Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-60.38M
↓ 13% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-53.60M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-60.38M | -2319.0% |
| 2024 | $-2.50M | +97.3% |
| 2023 | $-91.47M | +7.6% |
| 2022 | $-99.01M | -23.5% |
| 2021 | $-80.19M | -45.8% |
| 2020 | $-55.00M | -36.3% |
| 2019 | $-40.34M | -27.9% |
| 2018 | $-31.54M | -43.5% |
| 2017 | $-21.98M | - |